Robin L Bailey Selected Research

Trachoma

1/2023	A systems serology approach to the investigation of infection-induced antibody responses and protection in trachoma.
2/2022	Prevalence of nasopharyngeal Streptococcus pneumoniae carriage and resistance to macrolides in the setting of azithromycin mass drug administration: analysis from a cluster-randomised controlled trial in Malawi, 2015-17.
1/2022	Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial.
1/2022	Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial.
1/2022	Genomics of Ocular Chlamydia trachomatis After 5 Years of SAFE Interventions for Trachoma in Amhara, Ethiopia.
1/2022	The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children.
6/2021	Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx.
1/2021	Surveillance for peri-elimination trachoma recrudescence: Exploratory studies in Ghana.
11/2020	Facial cleanliness indicators by time of day: results of a cross-sectional trachoma prevalence survey in Senegal.
1/2020	Responses of the putative trachoma vector, Musca sorbens, to volatile semiochemicals from human faeces.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robin L Bailey Research Topics

Disease

71	Trachoma 01/2023 - 04/2002
31	Infections 03/2024 - 11/2004
14	Cicatrix (Scar) 01/2020 - 04/2006
11	Inflammation (Inflammations) 01/2022 - 01/2013
11	Trichiasis 01/2017 - 03/2006
8	Malaria 01/2022 - 05/2014
5	Parasitemia 01/2020 - 05/2014
4	Eye Infections 03/2014 - 10/2005
3	Fibrosis (Cirrhosis) 01/2020 - 04/2006
3	Bacterial Infections (Bacterial Infection) 12/2017 - 01/2012
2	Pneumonia (Pneumonitis) 01/2020 - 01/2020
2	Corneal Opacity 01/2012 - 12/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Meningitis 01/2020
1	Dysentery 01/2020
1	Anemia 01/2020
1	Exanthema (Rash) 01/2019
1	Diarrhea 01/2019
1	Chlamydia Infections 01/2019
1	Vomiting 01/2019
1	Body Weight (Weight, Body) 04/2018
1	Conjunctivitis 12/2017
1	Bacterial Conjunctivitis 12/2017
1	Schistosomiasis (Bilharziasis) 11/2016
1	Hypersensitivity (Allergy) 11/2016
1	Yaws 01/2015
1	Communicable Diseases (Infectious Diseases) 09/2014
1	Growth Disorders 09/2014
1	Conjunctival Diseases 01/2013
1	Entropion 01/2012
1	Metaplasia 01/2011
1	Reinfection 01/2009
1	Blindness (Hysterical Blindness) 01/2009

Drug/Important Bio-Agent (IBA)

41	Azithromycin (Zithromax)FDA LinkGeneric 02/2022 - 11/2004
22	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 07/2003
9	CytokinesIBA 01/2020 - 12/2004
4	AntigensIBA 01/2019 - 01/2011
3	AntibodiesIBA 01/2021 - 05/2012
3	VaccinesIBA 03/2014 - 08/2006
3	Interferon-gamma (Interferon, gamma)IBA 03/2014 - 12/2004
3	16S Ribosomal RNAIBA 01/2014 - 02/2006
3	DNA (Deoxyribonucleic Acid)IBA 07/2012 - 02/2006
2	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2012
2	MacrolidesIBA 02/2022 - 01/2017
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2008
2	ChemokinesIBA 01/2020 - 01/2012
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 09/2017
2	MucinsIBA 01/2019 - 01/2017
2	MicroRNAs (MicroRNA)IBA 02/2016 - 01/2013
2	RNA (Ribonucleic Acid)IBA 02/2016 - 12/2011
2	LigandsIBA 03/2014 - 01/2012
2	Nucleic AcidsIBA 07/2012 - 02/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 12/2004
2	S100 Calcium Binding Protein A7IBA 01/2012 - 01/2012
2	Metalloproteases (Metalloproteinases)IBA 01/2012 - 12/2004
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2008 - 03/2006
2	InsecticidesIBA 04/2004 - 04/2002
1	Deubiquitinating EnzymesIBA 03/2024
1	Phospholipase DIBA 03/2024
1	TARPIBA 03/2024
1	Immunoglobulin G (IgG)IBA 01/2023
1	AnthelminticsIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 11/2020
1	Antimicrobial PeptidesIBA 01/2020
1	Pheromones (Semiochemicals)IBA 01/2020
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 01/2020
1	InterleukinsIBA 01/2020
1	Merozoite Surface Protein 1 (MSA1)IBA 12/2019
1	InterferonsIBA 01/2019
1	Antimalarials (Antimalarial Agents)IBA 01/2019
1	Praziquantel (Biltricide)FDA Link 11/2016
1	Immunoglobulin E (IgE)IBA 11/2016
1	CollagenIBA 01/2016
1	HLA-C Antigens (HLA-C)IBA 03/2014
1	Messenger RNA (mRNA)IBA 01/2013
1	Ribosomal RNAIBA 07/2012
1	Immune Sera (Antisera)IBA 05/2012
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2012
1	Amyloid (Amyloid Fibrils)IBA 01/2012
1	Interleukin-17 (Interleukin 17)IBA 12/2011
1	Silk FDA Link 12/2011
1	antineoplaston A10 (A 10)IBA 12/2011
1	AgarIBA 07/2011
1	Keratins (Keratin)IBA 01/2011
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 08/2010
1	Tissue Inhibitor of Metalloproteinase-1IBA 07/2010
1	Matrix Metalloproteinases (MMPs)IBA 07/2010
1	Immunoglobulin A (IgA)IBA 01/2008
1	dimemorfan (AT 17)IBA 01/2008
1	EpitopesIBA 01/2008
1	Transcription Factors (Transcription Factor)IBA 08/2006
1	Amino Acids FDA Link 04/2006
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 04/2006
1	EnzymesIBA 04/2006
1	Peptides (Polypeptides)IBA 03/2006

Therapy/Procedure

16	Mass Drug Administration 01/2022 - 01/2009
4	Hair Removal (Depilation) 03/2016 - 03/2006
3	Aftercare (After-Treatment) 03/2014 - 11/2004
1	Sutures (Suture) 12/2011
1	Therapeutics 11/2011